Enzalutamide in castration-resistant metastatic prostate cancer treatment, an Oporto’s center experience

2019 ◽  
Vol 18 (11) ◽  
pp. e3459
Author(s):  
J. Reis ◽  
I. Costa ◽  
C. Borges ◽  
J. Simões ◽  
C. Caeiro ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Cancer Treatment ◽  
Metastatic Prostate Cancer ◽  
Prostate Cancer Treatment ◽  
Castration Resistant

scholarly journals Patient and caregiver benefit‐risk preferences for nonmetastatic castration‐resistant prostate cancer treatment

2020 ◽  
Vol 9 (18) ◽  
pp. 6586-6596 ◽  
Author(s):  
Sandy Srinivas ◽  
Ateesha F. Mohamed ◽  
Sreevalsa Appukkuttan ◽  
Marc Botteman ◽  
Xinyi Ng ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Cancer Treatment ◽  
Risk Preferences ◽  
Castration Resistant Prostate Cancer ◽  
Prostate Cancer Treatment ◽  
Castration Resistant

scholarly journals Physician preferences for non-metastatic castration-resistant prostate cancer treatment

BMC Urology ◽  
2020 ◽  
Vol 20 (1) ◽  
Author(s):  
Sandy Srinivas ◽  
Ateesha F. Mohamed ◽  
Sreevalsa Appukkuttan ◽  
Marc Botteman ◽  
Xinyi Ng ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Cancer Treatment ◽  
Castration Resistant Prostate Cancer ◽  
Prostate Cancer Treatment ◽  
Castration Resistant

Theranostic 64Cu-DOTHA2-PSMA for metastatic prostate cancer treatment, a preclinical study

2020 ◽  
Vol 138 ◽  
pp. S24
Author(s):  
M.C. Milot ◽  
O. Bélissant Benesty ◽  
V. Dumulon-Perreault ◽  
S. Ait-Mohand ◽  
É. Rousseau ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Cancer Treatment ◽  
Metastatic Prostate Cancer ◽  
Preclinical Study ◽  
Prostate Cancer Treatment

Radium223—Where Does It Fit in the Metastatic Castration-resistant Prostate Cancer Treatment Landscape?

2015 ◽  
Vol 11 (02) ◽  
pp. 135
Author(s):  
Tanya B Dorff ◽  
Keyword(s):  
Prostate Cancer ◽  
Cancer Treatment ◽  
Cancer Patients ◽  
Castration Resistant Prostate Cancer ◽  
Prostate Cancer Treatment ◽  
Castration Resistant ◽  
Significant Interest ◽  
Osseous Involvement ◽  
Defining Sequence

Radium223 is approved for symptomatic castration-resistant prostate cancer patients with osseous involvement. Selecting patients and defining sequence strategies are challenging, with the limited available data, but there is a trend toward greater impact in higher volume disease. Combination and/or consolidation strategies for Radium223 will be of significant interest as data emerge from ongoing trials.

scholarly journals MP84-11 BONE MICROENVIRONMENT TARGETED NANOPARTICLES FOR METASTATIC PROSTATE CANCER TREATMENT

2016 ◽  
Vol 195 (4S) ◽  
Author(s):  
Andrew Gdowski ◽  
Amalendu Ranjan ◽  
Anindita Mukerjee ◽  
Marjana Sarker ◽  
Joe Kimbell ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Cancer Treatment ◽  
Metastatic Prostate Cancer ◽  
Bone Microenvironment ◽  
Prostate Cancer Treatment ◽  
Targeted Nanoparticles
Sign in / Sign up

Export Citation Format

Share Document